YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923

Phase 1

Completed

Conditions: Alzheimer Disease

Interventions: Drug: BMS-984923

First Posted Date: 2021-03-18

Last Posted Date: 2024-08-27

Lead Sponsor: Yale University

Target Recruit Count: 36

Registration Number: NCT04805983

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Prazosin for Alcohol Use Disorder with Withdrawal Symptoms

Phase 2

Recruiting

Conditions: Alcohol Withdrawal

Interventions: Drug: Prazosin
Behavioral: 12-Step Facilitation with Relapse Prevention and Contingency Management

First Posted Date: 2021-03-11

Last Posted Date: 2025-02-21

Lead Sponsor: Yale University

Target Recruit Count: 150

Registration Number: NCT04793685

Locations: 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

Phase 1

Completed

Conditions: Obesity

Interventions: Drug: GLP-1 analogue - semaglutide
Other: Placebo

First Posted Date: 2021-03-03

Last Posted Date: 2025-02-12

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT04779697

Locations: 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States

Sex Differences in Neural Response to Cannabidiol

Early Phase 1

Completed

Conditions: Neural Responses
CBD

Interventions: Other: Placebo
Drug: Cannabidiol

First Posted Date: 2021-03-02

Last Posted Date: 2023-12-21

Lead Sponsor: Yale University

Target Recruit Count: 19

Registration Number: NCT04777643

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

Phase 2

Recruiting

Conditions: Intracerebral Hemorrhage
Ischemic Stroke
Spironolactone

Interventions: Drug: Spironolactone Pill

First Posted Date: 2021-02-18

Last Posted Date: 2025-04-11

Lead Sponsor: Yale University

Target Recruit Count: 200

Registration Number: NCT04760717

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 2 locations

Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

Not Applicable

Active, not recruiting

Conditions: Depression and Suicide

Interventions: Behavioral: Cognitive Behavioral Therapy CBT

First Posted Date: 2021-02-18

Last Posted Date: 2025-01-22

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04760652

Locations: 🇺🇸
UAB Medicine | Heersink School of Medicine, Birmingham, Alabama, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Stimulation Therapy for Inducing Mothers

Not Applicable

Completed

Conditions: Labor Pain
Labor Long
Breast Pumping
Lactation Induced
Induced; Birth

Interventions: Other: Exogenous oxytocin intravenous infusion
Device: Electronic breast pump

First Posted Date: 2021-02-16

Last Posted Date: 2021-09-05

Lead Sponsor: Yale University

Target Recruit Count: 24

Registration Number: NCT04756089

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Mindful Kala: Virtual Bharatanatyam Wellness Program for Students

Not Applicable

Completed

Conditions: Quality of Life
Cultural Competence
Stress

Interventions: Behavioral: A 4-week Bharatanatyam course from the organization Mindful Kala

First Posted Date: 2021-02-09

Last Posted Date: 2021-06-21

Lead Sponsor: Yale University

Target Recruit Count: 53

Registration Number: NCT04745364

Locations: 🇺🇸
Good Life Center, Yale University, New Haven, Connecticut, United States

Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease

Completed

Conditions: Common Femoral Artery Stenosis

First Posted Date: 2021-02-09

Last Posted Date: 2022-02-03

Lead Sponsor: Yale University

Target Recruit Count: 200

Registration Number: NCT04745624

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Mindfulness-Based ADHD Treatment for Children: a Feasibility Study

Early Phase 1

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: Mindfulness-Based ADHD Treatment for Children
Biological: Goal-Standard Medication (Treatment as Usual)

First Posted Date: 2021-02-04

Last Posted Date: 2024-11-25

Lead Sponsor: Yale University

Target Recruit Count: 68

Registration Number: NCT04737512

Locations: 🇺🇸
Clinical & Affective Neuroscience Lab, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy